Buprenorphine 5, 10 and 20 μg/h Transdermal Patch: A Review of its Use in the Management of Chronic Non-Malignant Pain

By Plosker Greg L.  

Drugs, Vol. 71, Iss. 18, 2011-12 ,pp. : 2491-2509

Adis International

Access to resources Recommend Favorite

A randomized, 14-day, double-blind study evaluating conversion from hydrocodone/acetaminophen (Vicodin) to buprenorphine transdermal system 10 μg/h or 20 μg/h in patients with osteoarthritis pain

By Ripa Steven R   McCarberg Bill H   Munera Catherine   Wen Warren   Landau Craig J  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 9, 2012-06 ,pp. : 1229-1241

Informa Healthcare

Access to resources Recommend Favorite

Use of Transdermal Fentanyl in Patients with Continuous Non-Malignant Pain: A Case Report Series

By Libretto S.E.  

Clinical Drug Investigation, Vol. 22, Iss. 7, 2002-07 ,pp. : 473-483

Adis International

Access to resources Recommend Favorite

Pharmacoeconomics of opioid therapy for chronic non-malignant pain

By Marcus Dawn A  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 3, 2002-03 ,pp. : 229-235

Informa Healthcare

Access to resources Recommend Favorite

Rivastigmine transdermal patch: a guide to its use in dementia of the Alzheimer's type

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 24, Iss. 4, 2008-04 ,pp. : 5-8

Adis International

Access to resources Recommend Favorite